Cagrilintide/semaglutide
A Research Study to Look at How Well CagriSema Helps People Living With Obesity Lose Weight and Maintain Weight Loss in the Long-term
Novo Nordisk · Phase 3 · Active, not recruiting · Enrollment 609
| Arm | Population | Dose | Weeks | Estimand | Weight change |
|---|---|---|---|---|---|
| CagriSema | Obesity or overweight | n/r | 4 | n/r | n/r |
| Placebo | Obesity or overweight | n/r | 4 | n/r | n/r |